AGM updates
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Mayne Pharma Group Ltd. has released an announcement regarding updates for its upcoming Annual General Meeting. The filing discusses the election of Dr. Brett Wells as a director and the delays in obtaining necessary background checks. It also outlines changes to the proxy form, including details on appointing multiple proxies and the Chair's voting intentions. Shareholders are reminded that they can vote 'For', 'Against', or 'Abstain' on resolutions presented at the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/agm-updates-1
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Investor presentation re International segment divestment
- Mayne Pharma to divest International segment for $55.5m
- Notification regarding unquoted securities - MYX
- Investor presentation
- Mayne Pharma reports unaudited Q1 FY27 results
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma